HealthAmerica Corporation – Trademark Portfolio
Entity Type: 03
HealthAmerica Corporation holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HEALTHAMERICA. The owner is based in Nashville, TN.
3310 West End Ave.
Nashville, TN 37203
Showing of trademarks Trademarks
Trademark Classifications
HealthAmerica Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does HealthAmerica Corporation have?
HealthAmerica Corporation has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 1 cancelled.
What trademark classes does HealthAmerica Corporation file in?
HealthAmerica Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are HealthAmerica Corporation's most well-known trademarks?
HealthAmerica Corporation's registered trademark portfolio includes well-known marks such as HEALTHAMERICA. These are among 1 currently registered trademark in the portfolio.
What is HealthAmerica Corporation's trademark registration success rate?
HealthAmerica Corporation has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.